CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

The company posted strong second-quarter results and reaffirmed its guidance for 2025. Enbridge posted EBITDA of C$4.6 ...

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...

Russia becomes the first country to deploy a cancer vaccine, launching trials within months. Using cutting-edge mRNA technology, the treatment is personalised to target a patient’s tumour. With ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The most special thing about a vaccine is that it not only controls or reduces the disease, but taking it does not cause the ...

If you want a Covid-19 shot this fall, will your employer’s health insurance plan pay for it? There’s no clear answer. But ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive surprises than negative ones.

BioNTech SE BNTX +3.21% Get Free Report reported a second-quarter per-share loss of $1.82 (1.60 euros) on Monday, up from a loss of 3.36 euros reported a year ago, compared to beating the consensus ...

Moderna, Inc.'s Q2 2025 earnings highlight a steep revenue decline post-pandemic, with just $0.1bn in revenue and a $(0.8bn) ...

Professor Watson is excited to announce the launch of an online summer course called “Ethics in the Workplace,” taught by Dr.

HOUSTON, TX / ACCESS Newswire / August 4, 2025 / EON Resources Inc. (NYSE American:EONR) (“EON” or the “Company”) is an ...